These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32683819)

  • 21. COVID-19 modeling based on real geographic and population data.
    Baysazan E; Berker AN; Mandal H; Kaygusuz H
    Turk J Med Sci; 2023 Feb; 53(1):333-339. PubMed ID: 36945958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating Effects of Dynamic Interventions to Control COVID-19 Pandemic: A Case Study of Guangdong, China.
    Liu Y; Liao C; Zhuo L; Tao H
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the case fatality rate based on stratification for the COVID-19 outbreak.
    Kim B; Kim S; Jang W; Jung S; Lim J
    PLoS One; 2021; 16(2):e0246921. PubMed ID: 33617534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary analysis on COVID-19 case spectrum and spread intensity in different provinces in China except Hubei province].
    Cheng C; Chen SY; Geng J; Zhu PY; Liang RN; Yuan MZ; Wang B; Jin YF; Zhang RG; Zhang WD; Yang HY; Duan GC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1601-1605. PubMed ID: 33297615
    [No Abstract]   [Full Text] [Related]  

  • 25. A sequential test to compare the real-time fatality rates of a disease among multiple groups with an application to COVID-19 data.
    Qu Y; Yin Lee C; Lam KF
    Stat Methods Med Res; 2022 Feb; 31(2):348-360. PubMed ID: 34878362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 outbreak in Wuhan demonstrates the limitations of publicly available case numbers for epidemiological modeling.
    Raimúndez E; Dudkin E; Vanhoefer J; Alamoudi E; Merkt S; Fuhrmann L; Bai F; Hasenauer J
    Epidemics; 2021 Mar; 34():100439. PubMed ID: 33556763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monte Carlo estimation of total variation distance of Markov chains on large spaces, with application to phylogenetics.
    Herbei R; Kubatko L
    Stat Appl Genet Mol Biol; 2013 Mar; 12(1):39-48. PubMed ID: 23459470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exact test of Hardy-Weinberg equilibrium by Markov chain Monte Carlo.
    Yuan A; Bonney GE
    Math Med Biol; 2003 Dec; 20(4):327-40. PubMed ID: 14969383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data.
    Marschner IC
    BMC Med Res Methodol; 2021 Jun; 21(1):126. PubMed ID: 34154563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and transmission of COVID-19 in community and household levels of Bangladesh: Longini and Koopman epidemic modelling approach.
    Rahman A; Marjan N; Afroz N; Afroz N; Hossain Z
    Int J Clin Pract; 2021 Dec; 75(12):e14921. PubMed ID: 34564915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Type I Half Logistic Burr-Weibull Distribution: Application to COVID-19 Data.
    Alshanbari HM; Odhah OH; Almetwally EM; Hussam E; Kilai M; El-Bagoury AH
    Comput Math Methods Med; 2022; 2022():1444859. PubMed ID: 36035288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients.
    Bellan M; Patti G; Hayden E; Azzolina D; Pirisi M; Acquaviva A; Aimaretti G; Aluffi Valletti P; Angilletta R; Arioli R; Avanzi GC; Avino G; Balbo PE; Baldon G; Baorda F; Barbero E; Baricich A; Barini M; Barone-Adesi F; Battistini S; Beltrame M; Bertoli M; Bertolin S; Bertolotti M; Betti M; Bobbio F; Boffano P; Boglione L; Borrè S; Brucoli M; Calzaducca E; Cammarata E; Cantaluppi V; Cantello R; Capponi A; Carriero A; Casciaro FG; Castello LM; Ceruti F; Chichino G; Chirico E; Cisari C; Cittone MG; Colombo C; Comi C; Croce E; Daffara T; Danna P; Della Corte F; De Vecchi S; Dianzani U; Di Benedetto D; Esposto E; Faggiano F; Falaschi Z; Ferrante D; Ferrero A; Gagliardi I; Gaidano G; Galbiati A; Gallo S; Garavelli PL; Gardino CA; Garzaro M; Gastaldello ML; Gavelli F; Gennari A; Giacomini GM; Giacone I; Giai Via V; Giolitti F; Gironi LC; Gramaglia C; Grisafi L; Inserra I; Invernizzi M; Krengli M; Labella E; Landi IC; Landi R; Leone I; Lio V; Lorenzini L; Maconi A; Malerba M; Manfredi GF; Martelli M; Marzari L; Marzullo P; Mennuni M; Montabone C; Morosini U; Mussa M; Nerici I; Nuzzo A; Olivieri C; Padelli SA; Panella M; Parisini A; Paschè A; Pau A; Pedrinelli AR; Percivale I; Re R; Rigamonti C; Rizzi E; Rognoni A; Roveta A; Salamina L; Santagostino M; Saraceno M; Savoia P; Sciarra M; Schimmenti A; Scotti L; Spinoni E; Smirne C; Tarantino V; Tillio PA; Vaschetto R; Vassia V; Zagaria D; Zavattaro E; Zeppegno P; Zottarelli F; Sainaghi PP
    Sci Rep; 2020 Nov; 10(1):20731. PubMed ID: 33244144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Mass Screening on the Number of Confirmed Cases, Recovered Cases, and Deaths Due to COVID-19 in Iran: An Interrupted Time Series Analysis.
    Taheri Soodejani M; Tabatabaei SM; Dehghani A; McFarland W; Sharifi H
    Arch Iran Med; 2020 Nov; 23(11):776-781. PubMed ID: 33220696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to particle Markov-chain Monte Carlo for disease dynamics modellers.
    Endo A; van Leeuwen E; Baguelin M
    Epidemics; 2019 Dec; 29():100363. PubMed ID: 31587877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk assessment of global COVID-19 imported cases into China].
    Shen SP; Wei YY; Zhao Y; Jiang Y; Guan JX; Chen F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1582-1587. PubMed ID: 32455514
    [No Abstract]   [Full Text] [Related]  

  • 36. Democracy and case fatality rate of COVID-19 at early stage of pandemic: a multicountry study.
    Yao L; Li M; Wan JY; Howard SC; Bailey JE; Graff JC
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):8694-8704. PubMed ID: 34490579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimate the incubation period of coronavirus 2019 (COVID-19).
    Men K; Li Y; Wang X; Zhang G; Hu J; Gao Y; Han A; Liu W; Han H
    Comput Biol Med; 2023 May; 158():106794. PubMed ID: 37044045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contagiousness and secondary attack rate of 2019 novel coronavirus based on cluster epidemics of COVID-19 in Guangzhou].
    Jing QL; Li YG; Ma MM; Gu YZ; Li K; Ma Y; Wu D; Wu Y; Luo L; Zhang ZB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1623-1626. PubMed ID: 32388933
    [No Abstract]   [Full Text] [Related]  

  • 39. A tutorial introduction to Bayesian inference for stochastic epidemic models using Markov chain Monte Carlo methods.
    O'Neill PD
    Math Biosci; 2002; 180():103-14. PubMed ID: 12387918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the survival times of the COVID-19 patients with a new statistical model: A case study from China.
    Liu X; Ahmad Z; Gemeay AM; Abdulrahman AT; Hafez EH; Khalil N
    PLoS One; 2021; 16(7):e0254999. PubMed ID: 34310646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.